SEC Form 4 · accession 0001209191-17-000952
Alaunos Therapeutics, Inc. · TCRT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Weiser
Director
Period of report
Dec 30, 2016
Accepted (ET)
Jan 4, 2017 · 4:35 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001107421
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 30, 2016 | A | 17,204 | $0.00 | A | 213,001 | D | |
| Common StockF2 | Dec 31, 2016 | F | 9,331 | $5.35 | D | 203,670 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F117,204 shares shall vest on 12/30/2017.
- F2Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock grants.